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SIXTY·THIRD HONOR LECTURE 
DELIVERED AT THE UNIVERSITY 
A basic objective of the Faculty Association of Utah State Uni-
versity, in the words of its constitution, is: 
to encourage intellectual growth and development of its members 
by sponsoring and arranging for the publication of two annual 
faculty research lectures in the fields of (1 ) the biological and 
exact sciences, including engineering, called the Annual Faculty 
Honor Lecture in the Natural Sciences; and (2) the humanities 
and social sciences, including education and business administra-
tion, called the Annual Faculty Honor Lecture in the Humanities. 
The administration of the University is sympathetic with these aims 
and shares, through the Scholarly Publications Committee, the costs of 
publishing and distributing these lectures. 
Lecturers are chosen by a standing committee of the Faculty 
Association. Among the factors considered by the committee in choosing 
lecturers, are in the words of the constitution: 
( 1) creative activity in the field of the proposed lecture; (2) pub-
lication of research through recognized channels in the field of the 
proposed lecture ; (3) outstanding teaching over an extended 
period of years; (4 ) personal influence in developing the character 
of the students. 
Thomas Emery was selected by the committee to deliver the Annual 
Faculty Honor Lecture in the Sciences. On behalf of the members of 
the Association we are happy to present Professor Emery's paper. 
Committee on Faculty Honor Lecture 

Iron: The Problem 
IRON AND LIFE 
by 
Thomas Emery* 
Iron, iron, everywhere but. . . . The plight of the ancient mariner 
surrounded by undrinkable water could hardly have been more frus-
trating than life on earth with respect to iron. Iron is the fourth most 
abundant element of the earth's surface, exceeded only by oxygen, silicon, 
and aluminum. Virtually all forms of life from the simplest bacteria to 
humans require iron to catalyze numerous and complex metabolic 
reactions. Because of the diversity and complexity of the role of iron 
in the life process, it has even been suggested that the origin of life 
on earth centered around the catalytic properties of this metal. But 
in spite of its abundance, the acquisition of iron for cellular needs is a 
formidable problem. The fact that one of every four persons in western 
civilization suffers from iron-deficiency anemia is testimony to the fact 
that the problem has not been resolved. 
To understand the nature of the problem itself, we need only to 
review what we learned about iron in freshman chemistry. In solution, 
iron commonly occurs as either the ferrous form, Fe++, or the ferric form, 
Fe+++. The ferrous form is quite soluble even at the neutral conditions of 
living cells. In contrast, if one neutralizes an acidic solution of the ferric 
ion, the iron precipitates out of solution under conditions which are still 
one hundred times more acidic than water itself. In fact, a simple 
calculation shows that in the neutral environment of living cells only 
one or two atoms of iron could remain in solution within the cell. When 
life evolved on earth, there was no oxygen in the atmosphere. Iron thus 
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remained in the ferrous state, and in this soluble form it was plentiful 
in the oceans and other bodies of water. With the evolution of photo-
synthesis, oxygen appeared in the atmosphere. Very quickly the ferrous 
form of iron was oxidized to the ferric form. Geological evidence shows 
that vast deposits of ferric oxides were precipitated from the oceans at 
this time. Quickly the amount of dissolved iron decreased to an infini-
tesimal amount, far too small to support life. The manner in which the 
powerful forces of evolution allowed life to adapt to an environment 
virtually devoid of a soluble, utilizable form of iron will be the subject 
of this paper. Most of the research in this area involves microorganisms. 
However, a reader patient enough to follow the discussion to the end 
will be rewarded by learning of recent developments which may directly 
relate to his or her own health and well-being, facts which at the time of 
this writing are not widely appreciated even by practicing physicians. 
With the appearance of oxygen on earth, most of the iron soon 
became converted to insoluble ferric silicate or ferric oxide. The red 
color of many soils and rock formations, particularly striking in the cliffs 
and arches in the Southwest of the United States, is due to ferric oxide. 
Given a sample of ferric oxide which he wishes to solubilize, a chemist 
has two choices. First, he may simply add acid. In acid, the iron quickly 
dissolves to give a yellow solution of the ferric ion. The second method 
is to add a substance called a chelating agent. A chelating agent is an 
organic compound which has a strong affinity for metal ions and which 
literally pinches the metal like a pair of pliers. In fact, the word chelate 
derives from the Greek word, chele, meaning the claw of a lobster. 
In general, chelates are very soluble in water. 
Primitive living cells utilized the same method. In order to survive, 
they soon "learned" to synthesize relatively simple organic molecules that 
were effective chelating agents for iron. These substances were excreted 
into the environment where they effectively solubilized the metal. Because 
these natural iron chelates are colored bright red, we call them sidero-
chromes, from the Greek sideros, iron, and chroma, color. In addition 
to being chelating agents, many siderochromes are at the same time 
organic acids. We have recently observed in our laboratory that during 
the growth of certain iron-starved microorganisms, the excretion of 
siderochromes may be accompanied by an increase in acid concentration 
one thousand times above that of the original culture. Thus, nature 
utilizes the same tricks as the chemist (or vice versa) to solubilize iron. 
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Over a billion years elapsed before the first siderochrome was discovered 
in 1952 by Professor J. B. Neilands at the Berkeley campus of the 
University of California (Neilands, 1952). I became involved in the 
problem several years later. 
The Solution: Ferrichrome 
In the fall of 1956 I was a graduate student in the Biochemistry 
Department at Berkeley in quest of a thesis problem. I had almost 
decided to work in the laboratory of Professor Arthur Pardee. He had 
told me of a fascinating idea he had about how single cells could control 
their metabolic activity, and he patiently explained to me how he might 
be able to prove his idea by studying the inhibition of an enzyme called 
aspartate transcarbamoylase. It was an exciting idea, but in the end 
I decided not to work with Professor Pardee for two reasons. First, I was 
trained as an organic chemist, and enzymes frightened me a little. 
Second, Professor Pardee frightened me a lot. Instead, I chose Professor 
J. B. Neilands as my thesis supervisor. Another student, John Gerhardt, 
went to work with Professor Pardee and today is an internationally 
renowned biochemist for his important work on the aspartate trans-
carbamoylase enzyme. 
Several years before my arrival as a student at Berkeley, Neilands 
had been carrying out research in microbial iron metabolism. He had 
chosen to study a fungus, Ustilago sphaerogena, because this organism 
had been reported to have an exaggerated iron metabolism. When 
grown in a normal, iron-containing medium, U. sphaerogena produces 
up to 1 % of its own weight in an iron protein, cytochrome c. Neilands 
observed that when the organism was deprived of iron it excreted large 
amounts of a new substance which turned deep red when iron was 
added to it. Neilands was able to isolate and crystallize small amounts 
of this new iron compound. Because it contained ferric ion and it was 
brightly colored, he named it ferrichrome. One day as I passed Neilands 
in the hallway of the Biochemistry building he thrust a small vial con-
taining about twenty-five milligrams of ferrichrome into my hand and 
said to me, "I hear you are looking for a thesis problem. If you want 
a good one, figure out the chemical structure of this stuff. " I decided 
to accept the challenge, not knowing that another student had spent 
nearly two years on the problem and left in discouragement. 
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After eighteen months of hard work, I had accumulated five large 
notebooks of experimental data, but I knew no more about the structure 
of ferrichrome than did the previous student. Neilands had just left for 
a year's sabbatical leave in Sweden and England, and I was very dis-
couraged. Ferrichrome is a relatively small molecule, and it is noted 
for holding onto the iron extremely tightly. My chemical analyses had 
shown that, in addition to one iron atom, ferrichrome contained three 
molecules of acetic acid, three molecules of the amino acid, glycine, and 
some ornithine, an amino acid which is rather rare in biological mole-
cules. The amount of ornithine plagued me. Some days my analysis 
would yield 1.5 molecules of ornithine, some days almost none at all. 
At that time, one of the world's few functional amino acid analysis 
machines was located in the laboratory of Dr. Heinz Fraenkel-Conrat 
up in the virus area on the fifth floor, an area forbidden to graduate 
students. The machine was being used to decipher the structure of the 
coat protein of tobacco mosaic virus, work which would later bring fame 
to Dr. Fraenkel-Conrat. The machine was operated by a postdoctoral 
assistant to Dr. Fraenkel-Conrat, a gentle Japanese fellow named Dr. 
Tsugita. One day at 2 o'clock in the morning I sneaked up on the fifth 
floor and handed Dr. Tsugita a hydrolysate of ferrichrome, explaining 
to him that I would be forever indebted if he would be willing to run my 
sample through the amino acid analyzer. After making me promise that 
Professor Fraenkel-Conrat would never know, he agreed to do it for me. 
(Fraenkel-Conrat still does not know. I assume that he will not read this 
essay.) I shall never forget my excitement the next day when Dr. Tsugita 
came running up to me with his yards of paper recordings taken from 
the machine. Of course, the three molecules of glycine clearly showed up, 
but how much ornithine, I asked. None at all was the answer, but 
instead Dr. Tsugita showed me a peak which agreed with no known 
amino acid. Off to Val's Pizza Parlor to celebrate our discovery of a 
new amino acid! Dr. Tsugita made me swear that I would not mention 
'his name in my thesis for fear that Professor Fraenkel-Conrat would 
throw him out of the lab for using the analyzer for something other than 
tobacco mosaic virus. 
One month later, after many long hours of experimentation and 
much sweat, I was able to firmly establish the structure of the new 
amino acid as a derivative of ornithine, 8-N-hydroxyornithine. It is the 
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ammo acid ornithine in which one of the nitrogen atoms has been 
substituted with an - OH group : 
~Hz 
HzN - (CH Z)3- CH - COOH 
ornithine 
NH" I -
HO-NH -( CH z)3- CH - COOH 
8 -N -hydroxyornithine 
This compound had never before been reported in the literature, and 
only a few other examples of hydroxylamino acids were known. I real-
ized that the reason for the previous ambiguous analyses was that traces 
of iron would cause variable amounts of N-hydroxyornithine to be con-
verted to ornithine during acid hydrolysis of ferrichrome. I was able to 
put this fact to use in order to determine how much N-hydroxyornithine 
was actually present in the ferrichrome molecule. By carrying out the 
hydrolysis with hydriodic acid instead of hydrochloric acid, the - NOH 
group was quantitatively reduced to an - NH2 group, yielding ornithine 
cleanly. Exactly three molecules were found , proving that ferrichrome 
itself contained three molecules of N-hydroxyornithine. Armed with 
this information, I could account for all of the parts of the ferrichrome 
molecule and correctly draw its complete structure : 
FIGU RE I. The structure of ferrichrome. 
Consequently, instead of writing a monstrous thesis describing unsuccess-
ful experiments on the ferrichrome molecule, I was able to write the 
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shortest Ph.D. thesis in the department, entitled simply "The Structure 
of Ferrichrome." One picture is worth 10,000 words to an organic 
chemist! 
Our first publication on the structure of ferrichrome appeared in 
the Journal of the American Chemical Society in 1961 (Emery and 
Neilands, 1961). As so often occurs in science, within a few months 
the structure of another siderochrome was published. A group in 
Switzerland, unknown to our laboratory at that time, had independently 
isolated an iron-chelating agent, which they called deferrioxamine, and 
they had determined its chemical structure (Keller-Schierlein and Prelog, 
1961 ) . Since that time, several dozen similar compounds have been 
discovered. In fact, it appears to be a general rule that if a microorgan-
ism is starved for iron, it will excrete a siderochrome into the environment 
to sequester that metal (Emery, 1978). It is interesting that micro-
biologists had previously overlooked this almost universal phenomenon 
despite the fact that several grams df siderochrome are frequently pro-
duced in each liter of culture medium. 
Examining the structure of ferrichrome or similar siderochrome 
indicates that the Fe+++ is surrounded by six oxygen atoms located at the 
six corners of a regular octahedron. This is the type of chelation chem-
istry that Fe+++ prefers. The groups which supply these oxygens are called 
hydroxamic acids, - CO- NHOH. There are three of these in the ferri-
chrome molecule, each supplying two of the six oxygens that surround 
the metal. When several chelating groups are found on the same mole-
cule, a phenomenon called the "chelate effect" is produced, making the 
affinity for the metal much greater than if the groups were on individual 
molecules. Thus, ferrichrome binds Fe+++ approximately a million times 
more strongly than simple hydroxamic acids. Although organic chemists 
have known for almost three quarters of a century that hydroxamic acids 
form strong complexes with iron, no one had ever thought of putting 
three such groups on the same molecule to give a super iron-binding 
substance. It is testimony to the power of evolutionary forces that this 
mechanism was initially utilized by simple microorganisms over a billion 
years ago. It also provides me with an excuse as to why I did not 
discover the structure of ferrichrome sooner. No compound, either natur-
ally occurring or synthetic, containing three hydroxamic acid groups was 
known prior to the discovery of ferrichrome. 
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The Role of Ferrichrome as Nature's Gcritol 
How does ferrichrome work to solve the cell 's problem of iron 
assimilation? When faced with iron starvation, a complex control system 
alerts the cell to impending disaster. Although we still do not understand 
the molecular details, we do know that cellular protein synthesis is 
diminished and cellular pools of amino acids are instead diverted to the 
synthesis of deferriferrichrome, i.e., the organic part of the ferrichrome 
molecule lacking the iron. It is as if the cells realize that further synthesis 
of proteins will be useless without iron. The deferrifcrrichrom e is 
excreted from the cell where it solubilizes iron in the environment. 
The iron-binding properties of this substance are so great that in the 
laboratory iron is actually pulled out of Pyrex glassware or stainless steel ! 
In nature, oxides of iron are readily solubilized . When the FeH + is 
chelated, each of the three hydroxamic acid groups loses a proton, 1P, 
to leave three negative charges on the molecule. These three negative 
charges balance the three positive charges of the Fe+++ to give an elec-
trically neutral molecule. This is important because charged molecules 
have a difficult time traversing cellular membranes. In addition, as the 
ferrichrome wraps itself about the iron a dramatic change in shape, 
called a conformational change, occurs. The cell can therefore readily 
distinguish between the iron-free molecule, which is excreted, and the 
iron chelate, which is taken up by the cells. 
In 1957, my professor, J. B. N eilands, suggested that ferrichrome 
acts as a transport agent to get iron into the cells (Neilands, 195 7) . 
It was not until 1971 that work in my laboratory provided definite 
evidence that his suggestion was correct. The organism that produces 
ferrichrome, Ustilago sphaerogena, possesses a specific transport system 
which virtually sucks ferrichrome up from the surroundings, thus con-
centrating iron within the cells (Emery, 1971 ) . It is generally believed 
now that no metal ion can freely enter the cell. Specific chelating agents 
are probably produced and act in a manner similar to ferrichrome to 
sequester other essential metals, such as magnesium and zinc. Chelates 
that carry metal ions into the cells are called ionophores, literally mean-
ing " to carry ions." Ferrichrome can be considered to be a ferric 
ionophore. The general term for an iron transport substance is sidero-
phore, " to carry iron. " Ferrichrome was the first metal transport 
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system to be examined, and it has been intensively studied during the 
past decade. 
Before leaving this discussion of iron transport, one final point 
must be clarified. Cells utilizing a siderophore transport system have 
seemingly painted themselves into a corner. They have succeeded in 
accumulating iron, but it is in an unavailable form. Siderophores bind 
iron so tenaciously that no other cellular substance is capable of remov-
ing it. The solution to this problem is simple and is based on the 
principle that hydroxamic acids bind ferric, Fe+++, very strongly but they 
have virtually no affinity for ferrous ion, Fe++. Thus, the cell merely has 
to reduce the metal and it will be released from the chelate. Numerous 
workers have shown that cells contain specific enzymes, called siderophore 
reductases, which catalyze this reaction. Siderophores bind Fe+++ billions 
of times more strongly than Fe+, and no other known substance shows 
this extreme preference for the oxidized form of iron. Once the iron 
has been removed, the organic portion of the molecule can be excreted 
again to pick up some more iron. Ferrichrome thus acts as a "bucket 
brigade," shuttling in and out of the cell carrying iron rather than water. 
Who Cares? 
Each month Senator William Proxmire awards to some scientist 
what he calls the "golden fleece award." The award is made to the scien-
tist who, in Senator Proxmire's opinion, has been given federal funds to 
carry out a stupid research project. Over the past fifteen years, millions 
of dollars of federal funds have been awarded to scientists around the 
world in order to carry out basic research on iron metabolism in some 
of the weirdest microorganisms imaginable. How can this be justified? 
Out of fear that I may be the next recipient of the golden fleece award, 
I would like to devote the remainder of this essay to discuss some of the 
ways this research has led to practical benefits in terms of human health. 
Iron Overload-Too Much of a Good Thing 
Everyone is familiar with the problem of iron-deficiency anemia, 
a problem in which too little iron is absorbed from the intestines into the 
blood stream. The opposite problem, iron overload, is less well known 
because it is much rarer. On the other hand, it is usually much more 
senous. Unlike iron-deficiency anemia, iron overload is often fatal. 
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There are basically two reasons why iron overload may occur. The first 
is due to a rare disease, called haemochromatosis (Dreyfus and Schapira, 
1960). For unknown reasons, people with this affliction absorb too 
much iron. Most normal adults absorb about one milligram of iron per 
day from the diet (menstruating women need about twice this amount 
because of monthly blood losses ). In order to maintain iron balance, 
we must also excrete one milligram of iron per day. Amazingly, humans 
do not possess a metabolic mechanism to handle iron excretion. Iron is 
apparently the only dietary element for which this is true. It is as if 
Nature has had such a difficult time assuring the adequate assimilation 
of iron that she decided that adequate iron excretion would never be 
a problem. Fortunately for most of us, the average amount of iron lost 
haphazardly each day almost exactly balances the amount we absorb. 
Individuals suffering from haemochromatosis absorb about two 
milligrams of iron per day, instead of one. Although this tiny amount of 
iron does not even cover the head of a pin, it amounts to prodigious 
quantities over the years. A normal individual contains three to four 
grams total body iron. By the age of forty, an individual with haemo-
chromatosis may have accumulated twenty or thirty grams of excess iron. 
The excess iron is found in many tissues, such as the liver. Since the 
tissue cannot hold such large amounts of iron, the metal actually deposits 
and death often ensues. The abnormal iron deposits are actually visible 
in the liver, and the disease is sometimes referred to as the "rusty 
liver disease." 
Haemochromatosis is a rare genetic disease, and most physicians 
probably never encounter a case. However, there is another form of the 
affliction which is far more common. It is called secondary haemo-
chromatosis. In this case, diet plays an important role. Certain diets 
greatly increase the amount of iron absorption. Excessive alcohol is an 
example (Geritol is 12 % alcohol). Cirrhosis of the liver is common in 
alcoholics. Although alcohol is almost certainly the primary factor, 
some investigators believe that the problem is exacerbated by increased 
iron absorption. Secondary haemochromatosis is common in VA hos-
pitals, where alcoholism is often encountered. Some people believe that 
the ruddy complexion (and high incidence of liver problems) of people 
living in southern France is not so much due to the sunny climate as it is 
to the high iron content of southern French wines - as much as sixteen 
milligrams per liter as compared to less than three milligrams per liter 
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for American wines. The most extreme example of secondary haemo-
chromatosis occurs in the Bantus of South Africa, who brew a beer in 
iron kettles. This beer, called kafir, contains over forty milligrams 
per liter, and it is not uncommon for an average Bantu male to consume 
over 100 milligrams of iron each day in the form of beer alone. Second-
ary haemochromatosis is a common form of death for Bantu males 
(Bothwell, 1960). 
Although primary haemochromatosis cannot be cured, it is obvious 
that the problem might be alleviated if the body could maintain an 
appropriate iron level. One way of doing this, still commonly practiced, 
is bloodletting. Another possibility is to administer a chelating agent, 
which would grab onto the metal and remove it from the tissues so that 
it might be excreted in a harmless form in the urine. Unfortunately, 
most chelating agents are not specific for one particular metal. A chelat-
ing agent such as ethylenediaminetetraacetate would not only effectively 
remove iron, but also other essential metals, such as calcium and zinc. 
As discussed above, however, siderophores produced by microorganisms 
are highly specific for Fe+++, which is the form of the iron deposited in 
the body. Vladimir Prelog, who was the leader of the Swiss group which 
isolated deferrioxamine in 1961 and is a recent winner of the Nobel Prize 
in chemistry, was the first individual to realize that this property of 
deferrioxamine might be useful in treating haemochromatosis. In collab-
oration with a haematologist, he initiated treatment on a seventeen-year-
old girl dying of primary haemochromatosis. The treatment consisted of 
infusing over one gram per day of deferrioxamine into the patient. 
The results were dramatic (see Figure 2). Although the normal excre-
tion of iron in the urine is less than one milligram per day, immediately 
after starting the treatment over fifteen milligrams of iron appeared in 
the urine and reached a maximum of almost forty milligrams on the 
tenth day. Similar results were obtained with other patients. Because of 
the red color of the ferrioxamine chelate, the urine of patients during 
treatment resembled port wine, which was very alarming to nurses not 
alerted to the situtation ! 
Soon after the discovery of this medical use of siderophores, the 
Ciba-Geigy pharmaceutical company started growing large quantities of 
the microorganism and sending deferrioxamine to hospitals around the 
world in fifty-pound sacks. This was most impressive to me, having 
accomplished my thesis research on just a few hundred milligrams of 
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FIGURE 2. Urinary excretion of iron in a patient suffering from 
haemoc hromatosis after administration of deferriox-
amine. Taken from Wohler ( 1960) . 
ferrichrome. Deferrioxamine is now packaged under the trade name of 
Desferal. Unfortunately, however, continued infusions of large amounts 
of Desferal over long periods of time lead to undesirable side effects, 
which is why bloodletting is still performed on haemochromatosis 
patients. In the United States, the National Institutes of H ealth is 
sponsoring ongoing research for the discovery or synthesis of new 
siderophores which will not exhibit deleterious side effects. Why not 
synthesize siderophores in the laboratory instead of being dependent upon 
those supplied by microorganisms? In fact, both the Swiss and the 
Japanese have reported the chemical synthesis of ferrichrome. However, 
the synthesis is tedious and the yields are very poor. The problem lies 
with the instability of one of the constituents of ferrichrome, namely, 
N -hydroxyornithine. 
A colleague, Dr. Richard Olsen, and I have recently been awarded 
a National Institutes of H ealth grant to attempt a novel chemical syn-
thesis of siderophores. You will recall that the iron is held in ferrichrome 
11 
by three hydroxamic acid groups, - CO-NOH. If one imagines the 
hydroxamic acid groups to be excised from the molecule and turned 
around, the following structural change would occur: 
~H3 <;:H3 /(H3 
c=o c=o c=o 
I I I 
N-OH N-OH N-OH 
~~~ ( ~( 
(GIY)3 
ferrichrome 
<;:H3 ~H3 
N-OH N-OH 
I I 
c=o c=o 
(GIY)3 
side-chain retroferrichrome 
FIGURE 3. Chemical comparison of ferrichrome and side-chain retroferrichrome. 
We call this new compound side-chain retroferrichrome. Inspection of 
molecular models indicates that this change would have little or no effect 
on the iron-binding center. Side-chain retroferrichrome should bind 
iron as well as ferrichromc itself. Although the two structures may 
appear similar, they are dramatically different to the synthetic organic 
chemist. Whereas in ferrichrome the - N- OH group is supplied by 
N-hydroxyornithine, in the new compound it is supplied by methyl-
hydroxylamine, CHaNHOH, a substance that can be bought in pound 
quantities. The amino acid attached to the ring system is no longer 
the rare, unstable, N-hydroxyornithine, but rather a substance called 
a-aminoadipic acid, which is also readily available commercially. Thus, 
side-chain retroferrichrome should be relatively easy to synthesize in the 
l.aboratory. We should also be able to make alterations in the molecule 
during chemical synthesis, and thus build into the molecule chemical and 
physical properties, such as greater or lesser water solubility, that might 
be medically advantageous. Availability of a series of synthetic derivatives 
could lead to the discovery of a substance that would not only be more 
effective in removing iron from the body, but could also be administered 
orally. In a recent symposium on iron metabolism, several participants 
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agreed, "There is consequently a serious need to develop iron chelating 
agents which can be used to combat iron overload. Unfortunately, those 
in common use today are not very satisfactory; they are by no means 
as effective as could be hoped and oral administration is not currently 
possible due to poor absorption" (May et at., 1978). We hope that our 
research may alter this situation, and at the same time avoid our becom-
ing recipients of Senator Proxmire's golden fleece award. 
I ron Poisoning 
Every year many small children around the world die of iron 
poisoning. It has been estimated that 10% of all childhood deaths from 
poisoning may be attributed to iron. We may ask two questions. First, 
why is a substance so essential to good health also poisonous? Second, 
why is iron poisoning so common? We do not know the answer to the 
first question. For unknown reasons, large amounts of iron cause massive 
tissue destruction in the gastrointestinal tract. Ingestion of large amounts 
of iron salts causes vomiting, collapse of the vascular system, and often 
death. The answer to the second question is simple - ignorance on the 
part of the parents. It is common medical practice for physicians to 
prescribe iron supplements for women during the third trimester of 
pregnancy. This is necessary to insure that the newborn will be supplied 
with an adequate amount of iron during the first few months of life. 
Consequently, bottles containing several grams of iron are often found 
within easy reach on the kitchen or bathroom shelf. It has always seemed 
incredible to me that aspirin is packaged in bottles requiring the intelli-
gence of Einstein and the strength of a gorilla to open, while bottles 
containing iron supplements can be opened easily with one hand. I also 
consider it an obscenity that the manufacturers of these supplements 
place the iron in candy-coated tablets, which closely resemble M & M 
candy. Thus, the small child supposedly sneaking a handful of candy 
actually may swallow several grams of iron. It is indeed tragic that by 
attempting to guarantee the health of her unborn child, a woman may 
carelessly cause the death of another child in the house. 
Several cases of childhood iron poisoning, and at least one case of 
adult iron poisoning, have occurred in the Cache Valley area within the 
past few years. Much to my dismay, one example is the child of a friend 
of mine in Smithfield. Fortunately, to the best of my knowledge, the 
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individuals are still alive-thanks to microbial iron metabolism. Desferal 
has found clinical use not only in cases of chronic iron overload, but 
also in cases of acute iron poisoning. Toxicology centers and hospital 
pharmacies now usually have Desferal on hand. Large quantities of 
this natural iron-chelating agent are quickly administered to the patient. 
The Desferal travels throughout the body and rapidly binds the unwanted 
metal. The harmless Desferal-iron chelate, ferrioxamine, is excreted in 
the urine. 
Iron and Infectious Disease 
I would now like to turn to an area of human iron metabolism that 
has only recently received attention and is still somewhat controversial. 
This aspect of iron metabolism is not discussed in medical school cur-
ricula and is not generally appreciated by most practicing physicians. 
As previously mentioned, virtually all living cells require iron for 
growth and survival. One way to prevent bacteria from growing, and 
thus to prevent an infection, is to deprive them of iron. Nature appar-
ently discovered this obvious fact a long time ago. Egg whites contain 
an interesting protein called conalbumin. Conalbumin, sometimes called 
ovotransferrin, is very interesting in that it tightly forms a chelate with 
Fe+++. In fact, it is one of the few natural products which has an 
affinity for Fe+++ comparable to microbial siderophores. Unlike sidero-
phores, the iron is not held by hydroxamic acid groups, but rather by 
specific amino acid residues that surround the metal. Is this property 
of conalbumin merely fortuitous, or is there a reason? Most researchers 
in iron metabolism believe the latter. Eggs are an excellent incubation 
medium for bacterial growth. And eggs crack. Eggs are not usually 
located in the most sterile of environments, and a cracked egg is vulner-
able to bacterial infection. If this happened frequently, the species 
could not survive. We believe that nature supplied the egg with 
conalbumin to protect it from infection. All the available iron is chelated 
by the protein, and it is thus unavailable for bacterial growth. This is 
readily observed in the laboratory. A small amount of conalbumin added 
to a bacterial culture prevents growth. We can only speculate as to how 
important this phenomenon is in nature. However, a former student of 
Professor Neilands, John Garibaldi, made an interesting observation 
several years ago (Garibaldi, 1962). At that time there was a severe 
problem with egg spoilage in certain regions of central California. 
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Dr. Garibaldi reasoned that if the well water used by ranchers to wash 
eggs contained a high concentration of iron, the conalbumin might 
become saturated with the metal. Once the capacity of conalbumin was 
exceeded, the excess iron would be available for bacterial growth, leading 
to spoilage. Dr. Garibaldi tested this hypothesis by analyzing the well 
water of different chicken ranches for iron content. He found a direct 
correlation between iron content and the amount of egg spoilage. 
Might such a mechanism operate in animals, including humans? 
The answer is probably yes. Certain parts of the body are especially 
vulnerable to infection. The eyes are an example. The mucous mem-
branes of the eye are constantly exposed to airborne bacterial infection. 
Dr. Alexander Fleming, the discoverer of penicillin, observed long ago 
that tears contained an enzyme, lysozyme, which catalyzes the destruc-
tion of bacteria by breaking apart their cell walls. The reader may be 
interested to know that the commercial source of lysozyme today is not 
tears, but egg white. If eggs contain both lysozyme and conalbumin for 
protection, might not the eyes also? While I was still a student in 
Neilands's lab, I considered this possibility and carried out some prelim-
inary experiments. Unfortunately, I could reach no conclusion. More 
recently, however, other scientists have indeed found that tears contain a 
protein that is extremely similar to conalbumin. It is called lactoferrin, 
and it binds iron almost exactly as strongly as conalbumin (Hoffer et al., 
1977). Because lactoferrin is not known to play any other biological role 
than binding iron, it seems logical to conclude that its role in the eye is to 
inhibit bacterial infection in the same manner that conalbumin pro-
tects eggs. 
Too il1uch of a Good Thing 
If a scarcity of available iron prevents bacterial growth, might not 
an individual's susceptibility to infectious diseases be closely related to 
his or her iron nutrition? Although there is no evidence at present that 
eye infections are related to iron abundance, there is an increasing body 
of medical literature that such a relationship does exist in blood. 
When most of us think about iron in humans, we rightly think of 
blood. About 75 % of all of our iron occurs in the blood, and most 
people know that the red color of blood is due to the iron-containing 
protein, hemoglobin. You would hardly think that a bacterium entering 
the blood through a cut or a scratch would have to worry about a 
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scarcity of iron. But this is exactly what occurs. The iron is packaged 
inside of the red blood cell and is not accessible to the bacterium. 
In fact, it is not even accessible to the other cells of the body. Neverthe-
less, our blood is responsible for transporting iron from the intestinal 
tract, where it is absorbed, to all other tissues. This is not the role 
of hemoglobin, however, but rather this job is delegated to a protein 
called transferrin, occurring in the plasma rather than in the red blood 
cell. Transferrin is a protein perfectly designed to bind Fe+++ strongly, 
and it may come as no surprise at this time to learn that transferrin 
bears an amazing resemblance to lactoferrin and conalbumin. 
For all practical purposes, the only available source of iron for a 
microorganism finding itself in the bloodstream is the iron bound by 
transferrin. But transferrin binds iron with an extraordinary tenacity. 
How can the microorganism remove it? Simply by doing what it does 
under our laboratory conditions of iron deprivation, that is, by excreting 
a siderophore into the blood plasma. The binding strength of sidero-
phores and transferrin for Fe+++ is almost identical, so a competition 
begins between your own transferrin and the microbial siderophore. 
If the siderophore wins, you are faced with an infection. This relation-
ship between the iron nutritional status of an individual and the suscepti-
bility to infectious disease has been discussed in detail by E. D. Weinberg 
( 1978). I would like to cite a specific example. 
About ten years ago it was common practice in certain New Zealand 
hospitals to give iron supplements to infants soon after birth (Barry and 
Reeve, 1973). This practice was stopped when it was found that the 
incidence of certain bacterial infections was eight times higher in the 
treated infants than in infants who were left alone. Thus, in a well-
intentioned effort to make children "stronger" by increasing their iron 
levels, the doctors were actually increasing the chances that children 
would be exposed to potentially fatal infections. According to Sussman, 
"Iron plays an important part in determining virulence and possibly even 
pathogenicity in experimental infection" (Sussman, 1974 ) . Weinberg 
. has called this phenomenon "nutritional immunity." 
According to the concept of nutritional immunity, an animal may 
protect itself against certain infections by maintaining its iron nutritional 
status at a lower level than is commonly thought to be ideal for good 
health. A rosy complexion has always been regarded as a sign of health. 
Within the past few years, however, a large body of medical research 
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is beginning to suggest that borderline iron-deficiency anemia may not 
always be as bad as it appears at face value. It has been known for a 
long time that at the onset of some infections, iron absorption from the 
intestines rapidly decreases. This observation is easy to interpret if one 
accepts the concept of nutritional immunity, i.e., the body is making 
every effort to deprive invading microorganisms of iron to delay their 
growth so that our immune system can destroy them. A human will not 
die if deprived of iron for days, or even weeks. Rapidly growing bacteria 
cannot fare so well without iron. As previously mentioned, because of 
menstrual iron losses women have greater demands for dietary iron than 
men. Women tend to suffer from iron-deficiency anemia much more 
than men. Is it not possible that women's greater resistance to infection is 
related to their lower levels of body iron? 
Babies and I ron Nutrition 
Except for the immediate threat of starvation, infection poses the 
greatest hazard for the survival of the newborn child. Like eggs, the 
infant is constantly exposed to bacteria. It is not surprising that nature 
has evolved numerous devices to protect the infant; without such protec-
tion, it is likely that none of us would be here. In this section I would 
like to briefly discuss infant survival with respect to iron nutritional status. 
It is generally agreed that human milk is the ideal food for the 
newborn. Beverly Winikoff has written a fascinating article relating 
breast feeding to nutrition, population, and health (Winikoff, 1978). 
Breast milk not only contains a near ideal combination of easily digestible 
foods, but also an array of substances designed to immunize the child 
against infection. Surely iron, the indispensable element for life, has not 
been overlooked? An article clipped from the Logan Herald Journal of 
October 15, 1978, describes the concern of doctors about iron malnutri-
tion in infants. The article states that "iron must be replaced through 
iron from breast milk ... . " This is nonsense! Cow's milk contains less 
than one milligram of iron per quart, and human milk contains even less. 
To make matters even worse, milk contains the iron-binding protein 
lactoferrin. When lactoferrin binds iron, it changes its structure and 
becomes extremely difficult to be digested by intestinal enzymes. Nature 
has seemingly made every effort to make iron unavailable to the newborn 
child. How could she have erred so badly? 
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Iron experts believe that Nature has not erred at all, but rather that 
iron is purposely kept from the diet in order to protect the child from 
infection. Unlike the well-intentioned New Zealand doctors mentioned 
above, supplemental iron is actually kept away from the infant. Babies 
are born with more than enough iron to take care of their needs for 
months-just how many months is a matter of controversy. A great deal 
more research is needed to decide when, or if, supplemental iron should 
be added to the diet. 
There is an interesting sidelight to the low levels of iron in the diet 
of breast-fed infants and the development of the child's digestive system. 
As far as we know, iron is required by all forms of life with one excep-
. tion. The exception is the lactic acid bacteria. No one has yet been able 
to demonstrate an iron requirement for these organisms. These bacteria 
are found in the digestive tract of young animals, and they digest lactose, 
or milk sugar, so that the digestion products are absorbable by the 
intestine. Because of the virtual absence of iron in milk and the strong 
binding of what little iron there is by the lactoferrin protein, it is obvious 
that a microorganism could thrive in an infant's intestinal tract only if 
it had a negligible requirement for iron. 
I ron and Fever 
Warm-blooded animals have an elaborate physiological control 
system to maintain a constant body temperature. In man, this tempera-
ture is about 37°C. Any significant deviation from this temperature puts 
stress on the body and makes it difficult to maintain metabolic processes 
at their normal rates. Why then, during sickness, should the temperature 
rise? It would seem that development of fever would cause things to go 
from bad to worse, and make it more difficult for the body to recuperate. 
Fever is a complex and little understood phenomenon. Nevertheless, it is 
becoming more and more evident that fever can, in fact, be very benefi-
cial to an organism. It is common practice today to make every effort to 
reduce fever during illness. It would not surprise me at all if in the 
future we are told to let a fever run its course because of its benefit to 
the recuperative processes. I would like to discuss one aspect of fever as it 
relates to iron metabolism and infectious disease. 
Professor Matthew Kluger has recently written an article on the 
evolution and adaptive value of fever (Kluger, 1978). He cites an 
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interesting study by Vaughn, who investigated the survival of desert 
lizards, iguanas, after infection with a pathogenic bacterium. Reptiles 
cannot regulate their body temperature. When placed in a chamber that 
is held at SO°C at one end and 30°C at the other end, they will move 
back and forth to try to adjust their bodies to a preferred temperature 
of 38 ° C. However, after infection, they spent more time at the hot end 
of the chamber, purposely raising their body temperature. If they were 
not allowed to do this, their survival rate decreased. Below is a graph 
of a similar study by Kluger and collaborators who infected iguanas 
with bacteria and then kept groups of the infected lizards at different 
temperatures. 
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FIGURE 4. Survival rate of desert iguanas injected with a pathogenic bacterium, 
A. hydrophila, and then maintained at various temperatures. Numbers 
in parentheses are total number of animals in test group. From Kluger 
(1978 ). 
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The graph clearly shows that lizards held at "fever" temperature of 
42 °C survived quite well - much better than the animals held at their 
good health-preferred temperature of 38 ° C. The article goes on to cite 
similar studies with warm-blooded animals. 
Although the protective value of fever during infection must cer-
tainly be very complicated, I would like to point out one aspect which is 
related to iron. In the course of his studies on microbial siderophore 
biosynthesis, Garibaldi made an interesting observation (Garibaldi, 
1972). If the temperature of cultures was raised a few degrees above 
the normal growth temperature of 37 ° C, the organisms would survive 
quite well, but they ceased to produce siderophores. Garibaldi was the 
first to point out the possible medical significance of . this observation. 
Without iron, the bacteria cannot grow within the body. We have seen 
that during infection the body restricts the levels of blood plasma iron 
in order to make it more difficult for the microbes to grow. It may be 
possible that one of the reasons that fever is produced is to inhibit the 
ability of the microorganism to produce siderophores, which might other-
wise effectively compete for the last traces of iron in the blood plasma. 
Thus, normal body temperature and adequate iron nutrition may be 
just fine for people in good health, but may actually be detrimental at 
the onset of infection. 
Over 300 years ago, Sydenham said that "fever is a mighty engine 
which Nature brings into the world for the conquest of her enemies." 
Perhaps loss of appetite to restrict iron intake is one of the pistons of 
that engine. A popular old wives' tale is to "feed a cold but starve a 
fever." Fevers may be caused by bacterial infection, the infection being 
slowed by lack of iron. Colds are caused by viruses. Viruses do not 
contain iron! 
I ron and Plants 
It would be amiss for a professor at a land grant university, whose 
students are called Aggies, to conclude a discussion of iron without a 
word about the role of this element in agriculture. Just as in animals, 
many of the enzymes essential for plant life require iron. Perhaps most 
important, the biosynthesis of the green pigment, chlorophyll, also 
requires iron. Lack of iron leads to diminished chlorophyll synthesis and 
a yellowing of the plant. Such a condition is called chlorosis. Chlorosis is 
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common in alkaline soils, such as are often found in Utah, because of 
the extreme insolubility of oxides of iron in alkaline solution. Without 
sufficient chlorophyll, plants cannot carry out photosynthesis, and greatly 
diminished crop productivity results. Farmers and horticulturists have 
long recognized this problem and have made strenuous efforts to solve it. 
Many years ago children in Hawaii earned pocket money by taking iron 
turnings from foundry lathes and placing one turning on the top of each 
pineapple plant in the plantations. The acidity of these plants is appar-
ently sufficient to solubilize metallic iron. Today, synthetic iron chelates 
are used. The spraying of many tons of commercial iron chelates on 
agricultural crops, as well as on residential lawns, is a multimillion 
dollar industry. 
Most commercial iron chelates used for agricultural purposes are 
derivatives of a substance called ethylenediaminetetraacetate, or EDT A. 
EDTA forms a very stable chelate with Fe++..., and it is surprising that 
plants are able to remove the metal from this foreign compound. 
In order to do this, they must completely degrade the EDT A itself by 
metabolic processes. The final products of EDT A degradation are not 
known, but it is interesting that EDT A contains organic amines, which 
in some cases are known to be metabolically converted to cancer-
producing compounds. When one considers the many tons of EDT A 
sprayed on crops each year, it would appear that this is one area thus far 
overlooked for criticism by environmentalists. 
Quite obviously, plants were around long before EDT A was 
invented. How do plants cope with iron deficiency in nature? There is 
no evidence that higher plants mimic microorganisms and excrete sidero-
phores. However, they often excrete from the root system a complex 
mixture of organic acids. This mixture is generally called "humic acid." 
These acids apparently play the same role in plant iron metabolism that 
siderophores do in microorganisms. The soil becomes more acidic, thus 
increasing the solubility of iron. Furthermore, many of the acids, such as 
citric acid, are respectable chelators of iron, although not in the sidero-
phore class. Thus, plants make use of the same two principles for 
obtaining iron-acidity and chelation. Sometimes, this may actually 
work to the disadvantage of the plant. If the soil under the plant is 
porous, the solubilized iron may actually drain away from the root 
system. Epstein gives a dramatic example of this in the Kauri pine, 
Agathis australis, in New Zealand (Epstein, 1972). The tree is growing 
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on soil rich in oxides of iron, but the humic acids excreted by the tree 
have leached the iron away from under the tree, leaving a base of pure 
white silica behind. 
Although higher plants do not synthesize siderophores, I believe that 
siderophores may play an important role in plant iron nutrition. Species 
of the fungus fusaria are commonly found growing on plant roots. 
About fifteen years ago we found that this fungus excretes a powerful 
iron-binding siderophore, fusarinine C, when grown under iron depriva-
tion. In laboratory experiments, we subsequently found that fusarinine C 
could .be taken up by the root system of soybeans and tomatoes, and the 
iron was distributed to the leaves. Although growth of this fungus on 
plant roots is considered to be a pathological condition for the plant, 
it may be that under certain conditions a symbiotic relationship occurs 
wherein the soil microorganisms provide siderophores which serve to 
supply iron to the plants. This possibility has never been seriously 
investigated, although we have shown that siderophores are always found 
in randomly collected soil samples. If it were not for economic consid-
erations, the use of siderophores rather than EDT A in agricultural 
applications would be far more ecologically sound. 
Another observation that suggests that microbial siderophores may 
play an important role in iron nutrition in plants was reported by 
Neilands in an article entitled, "Ferrichrome Mimics the Green Island 
Effect" (Atkin and Neilands, 1972). It is sometimes observed that leaves 
yellow with chlorosis have small patches of green, which are called 
"green islands." They sometimes occur at the site of virus infection. 
Neilands made the interesting observation that green islands could be 
produced on leaves by the application of trace amounts of ferrichrome. 
The effect is specific for ferrichrome and can be produced by amounts 
as small as ten nanograms! These results strongly imply that ferrichrome 
is specifically supplying catalytic amounts of iron to allow chlorophyll 
synthesis to proceed in an otherwise defective leaf. 
Another line of evidence implicating siderophores in plant iron 
metabolism relates to copper. Plant scientists have long known that the 
presence of high concentrations of copper in the soil antagonizes the 
assimilation of iron, which leads to chlorosis. Copper is chemically very 
different from iron, and there is no obvious biochemical relationship 
between these two metals to suggest an explanation for the copper 
effect. However, it is known to chemists that hydroxamic acids - the 
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fundamental chelating groups of many siderophores-chelate with copper 
to form an insoluble blue precipitate. I observed many years ago that if 
the iron is removed from ferrichrome and copper is added to the colorless 
solution, a blue precipitate quickly forms. I would suggest, therefore, 
that when soil microorganisms excrete iron-free siderophores in their 
attempt to sequester iron from the soil, the copper-siderophore complexes 
precipitate and become unavailable for iron metabolism for both the 
microorganism and the plant. Although iron is bound to siderophore 
ligands much more strongly than copper, the latter metal is much more 
soluble, and the precipitation occurs before the iron has a chance to bc 
solubilized. Once the copper precipitate forms, it would be very difficult 
for iron to displace copper from the insoluble copper chelate. No one has 
ever examined soils in copper-rich regions to sec if copper-siderophore 
chelates are present. 
Conclusion 
In spite of many years of intensive research, some of the most funda-
mental problems of human iron metabolism remain unsolved, for 
example, the mechanisms by which iron is absorbed from the intestine 
and later released to the tissues according to need. Because of the relative 
simplicity of microbial systems, advances have come more quickly in this 
area. The detailed mechanism of iron transport in microbes is now quite 
well understood, and hopefully this understanding will be of value to 
future researchers in the medical sciences. 
I have described in this essay some of the ways in which research 
in microbial iron metabolism have already found applicability in medi-
cine. Microbial iron transport agents-the siderophores-are routinely 
used to remove excess metal in iron-storage diseases. Siderophores are also 
used as antidotes in cases of accidental iron poisoning in children. More 
recent work suggests that some accepted ideas about iron nutrition might 
have to be discarded. The prevalent attitude fostered by high-pressure 
advertising that "the more iron the better" may have to be reevaluated 
by a society that has become used to eating breakfast cereal with a 
magnet rather than a spoon. The common practice of iron supplementa-
tion in infancy must certainly be questioned, and the relationship of 
iron to fever and infectious disease should be a matter of intensive 
future research. In 1956, when Professor Neilands suggested to me that 
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working on microbial iron transport compounds might be an interesting 
problem for a Ph.D. thesis, neither of us could have guessed that this area 
of research might have so many future practical applications in the 
medical sciences. 
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